VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Abeona Therapeutics Inc. (ABEO) Total Return Calculator with Dividends Reinvested

Abeona Therapeutics Inc.

Popular:

The total return for Abeona Therapeutics Inc. (ABEO) stock is +9.49% over the past 12 months. So far it's up 8.66% this year. The 5-year total return is -85.01%, meaning $10,000 invested in ABEO stock 5 years ago would be worth $1,499 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in ABEO 1 year ago, it would be worth $10,510 today — you'd have gained $510.

With Dividends Reinvested$10,510+5.10%

Price Only (No DRIP)$10,510+5.10%

Period2025-05-08 → 2026-05-07

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in ABEO

1Y$10,949+$949 (+9.5%)9.5% CAGR

3Y$18,435+$8,435 (+84.3%)22.6% CAGR

5Y$1,499-$8,501 (-85.0%)-31.6% CAGR

10Y$931-$9,069 (-90.7%)-21.1% CAGR

15Y$21-$9,979 (-99.8%)-33.6% CAGR

20Y$34-$9,966 (-99.7%)-24.7% CAGR

30Y$136-$9,864 (-98.6%)-13.4% CAGR

Abeona Therapeutics Inc. did not pay dividends during this period. Total return = price return.

Loading ABEO total return...

As of 2026-05-08

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+8.66%	—	+8.66%	—	$10,866
1Y	+9.49%	9.49%	+9.49%	—	$10,949
3Y	+84.35%	22.62%	+84.35%	—	$18,435
5Y	-85.01%	-31.59%	-85.01%	—	$1,499
10Y	-90.69%	-21.14%	-90.69%	—	$931
15Y	-99.79%	-33.61%	-99.79%	—	$21
20Y	-99.66%	-24.72%	-99.66%	—	$34
30Y	-98.64%	-13.35%	-100.00%	+1.36 pp	$136

Risk & Highlights

Best Year+265.56%2009

Worst Year-84.88%2005

Max Drawdown-42.32%2025-08-22 → 2025-11-11

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-3.58%	-3.58%	—	+0.41%	-4.0pp
2025	-10.83%	-10.83%	—	+16.64%	-27.5pp
2024	+0.72%	+0.72%	—	+24.00%	-23.3pp
2023	+75.17%	+75.17%	—	+24.81%	+50.4pp
2022	-66.70%	-66.70%	—	-19.95%	-46.8pp

ABEO underperformed the S&P 500 by 20.88pp over the past year (+9.49% vs +30.37%).

Loading summary...

ABEO Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
ABEOAbeona Therapeutics Inc.	$318M	+20.0%	+8.7%	+9.5%	—	+84.3%	-85.0%	-90.7%
KRYSKrystal Biotech, Inc.	$8.7B	+12.4%	+20.2%	+116.9%	—	+238.5%	+319.2%	+2688.5%
RAREUltragenyx Pharmaceutical Inc.	$2.6B	+12.9%	+10.7%	-21.8%	—	-44.5%	-77.2%	-59.4%
FOLDAmicus Therapeutics, Inc.	$4.5B	+0.1%	+1.5%	+137.9%	—	+19.0%	+48.6%	+119.2%
ACADACADIA Pharmaceuticals Inc.	$3.9B	+2.2%	-13.7%	+52.4%	—	+4.7%	+7.1%	-22.9%
RCKTRocket Pharmaceuticals, Inc.	$398M	+5.5%	+6.1%	-45.2%	—	-82.8%	-91.6%	-91.3%
BEAMBeam Therapeutics Inc.	$3.2B	+28.5%	+16.0%	+93.9%	—	-5.6%	-55.6%	+67.8%
SGMOSangamo Therapeutics, Inc.	$22M	-60.5%	-77.0%	-84.4%	—	-92.0%	-99.0%	-98.4%
CRSPCRISPR Therapeutics AG	$5.1B	+5.5%	-2.5%	+53.1%	—	-6.3%	-51.3%	+272.0%
EDITEditas Medicine, Inc.	$297M	+10.6%	+47.8%	+127.8%	—	-68.5%	-91.1%	-90.0%
NTLAIntellia Therapeutics, Inc.	$1.6B	+1.2%	+48.9%	+88.1%	—	-68.3%	-79.8%	-42.9%

Compare:ABEO vs KRYS ABEO vs RARE ABEO vs FOLD ABEO vs KRYS vs RARE

About ABEO Dividend Returns

Abeona Therapeutics Inc. (ABEO) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of ABEO over the past year?

Abeona Therapeutics Inc. (ABEO) delivered a return of 9.49% over the past year. Since ABEO does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in ABEO be worth today?

A $10,000 investment in Abeona Therapeutics Inc. one year ago would be worth $10,949 today, representing a gain of $949.

Q3Does ABEO pay dividends?

Abeona Therapeutics Inc. (ABEO) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For ABEO, the total return equals the price-only return.

Q4Did ABEO beat the S&P 500?

No, Abeona Therapeutics Inc. (ABEO) underperformed the S&P 500 by 20.88 percentage points over the past year. ABEO delivered a total return of 9.49%, compared to the S&P 500's 30.37%. This means a passive S&P 500 index fund outperformed ABEO by 20.88pp during this period.

Q5What is ABEO's worst drawdown?

Abeona Therapeutics Inc. (ABEO) experienced a maximum drawdown of -42.32% over the past year, declining from its peak on 2025-08-22 to its trough on 2025-11-11. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is ABEO's long-term total return over 10, 20, or 30 years?

Here are Abeona Therapeutics Inc. (ABEO)'s long-term returns with dividends reinvested. Over 10 years, the total return is -90.7% (-21.1% CAGR) — $10,000 would have grown to $931. Over 20 years: -99.7% total return (-24.7% CAGR) — $10,000 → $34. Over 30 years: -98.6% total return (-13.4% CAGR) — $10,000 → $136. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was ABEO's best and worst year?

Abeona Therapeutics Inc.'s best calendar year was 2009 with a total return of 265.6%. Its worst year was 2005 with a total return of -84.9%. This range shows the volatility investors should expect — the difference between the best and worst year is 350.4 percentage points.